Atara Biotherapeutics' (ATRA) tabelecleucel (tab-cel) marketing application accepted by FDA for review on priority basis for ...

State Street is exploring the development of its own stablecoin and deposit token to get more involved in blockchain-based ...

Madison Covered Call and Equity Strategy Fund focuses on mid-cap value equities with a high distribution rate from option ...

New Fortress Energy faces significant balance sheet issues, leading to concerns about refinancing. Find out why I have a hold ...

On a m/m basis, housing starts increased by 3% month/month, but all the increase was a function of multi-family units, which ...

Bayer (BAYRY) plans to seek expanded label for prostate cancer therapy Nubeqa after successful Phase 3 trial results. Read ...

Hess ( NYSE: HES) +2.1% in Wednesday's trading as Bernstein upgrades shares to Outperform from Market Perform with a $172 ...

AbbVie Inc.'s upcoming Q2 earnings report, new CEO, and post-patent Humira revenue will be closely watched by Wall Street.

Bristol-Myers Squibb is underperforming the wider market, with bullish support yet to materialize. Read why we are ...

J.P. Morgan analysts listed the largest fund inflows and outflows in a Delta One Flows & Positioning report.

Saratoga Investment has started to send encouraging signals of improved fundamentals. Check out why I am hesitant to ...

Sitio's $200 million stock repurchase plan is irrational because it increases their financial leverage in a risky commodity ...